Rennova Health, Inc. RNVA today announced the pricing
of an underwritten public offering with expected total gross proceeds of
approximately $10,000,000 before deducting underwriting discounts and
commissions and other offering expenses payable by the Company.
The securities offered by the Company consist of Class A Units, with
each Class A Unit consisting of one share of the Company's common stock
and one immediately exercisable five-year warrant to purchase one share
of common stock with a warrant exercise price of $1.9375, and Class B
Units, with each Class B Unit consisting of one share of the Company's
Series C Convertible Preferred Stock with a stated value of $1,000 and
convertible into shares of the Company's common stock at $1.55
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in